Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
Clinical trial NCT03756103 · COMPLETED
Trial details
- NCT number
- NCT03756103
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2020-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.